Borger M A, Cohen G, Buth K J, Rao V, Bozinovski J, Liaghati-Nasseri N, Mallidi H, Feder-Elituv R, Sever J, Christakis G T, Bhatnagar G, Goldman B S, Cohen E A, Fremes S E
Division of Cardiovascular Surgery, Sunnybrook Health Science Center, University of Toronto, Ontario, Canada.
Circulation. 1998 Nov 10;98(19 Suppl):II7-13; discussion II13-4.
Left internal thoracic artery (LITA) grafts to the left anterior descending coronary artery (LAD) during coronary bypass surgery (CABG) have greater patency rates than saphenous vein grafts and reduce long-term cardiac morbidity and mortality rates. The benefits of multiple versus single arterial grafts and the role of different arterial conduits with respect to short- and medium-term outcome remains controversial. The purpose of this study was to compare the perioperative and intermediate-term results of: (1) patients receiving 2 arterial grafts versus 1 arterial graft and (2) patients receiving a right internal thoracic artery (RITA) versus a radial artery (RA) as the second arterial graft.
Retrospective analysis of prospectively gathered data on consecutive patients undergoing isolated CABG at our institution between 1989 and 1996 was conducted. The first section of the study compared outcomes for 1 arterial graft (LITA to LAD, n = 2333) versus 2 arterial grafts (LITA + RA or LITA + RITA, n = 378). The second section of the study compared outcomes for the RITA (n = 132) versus the RA (n = 171) as second arterial grafts since 1992, when the radial series was initiated. Part I: By multivariable stepwise logistic regression, the use of 1 arterial graft was associated with an increased incidence of perioperative cardiac morbidity and mortality (odds ratio 2.2, 95% confidence interval 1.4 to 3.3), with the use of our current patient selection criteria. Double-arterial graft patients had a nonsignificant trend toward increased intermediate-term actuarial survival (P = 0.12) and cardiac event-free survival (P = 0.09). Part II: Comparison of preoperative demographics revealed a higher incidence of diabetes (27% vs 11%, P < 0.001), peripheral vascular disease (16% vs 8%, P = 0.03), and elderly age (13% vs 2%, P = 0.001) in patients receiving an RA versus those receiving a RITA as the second arterial graft. Perioperative outcome analysis revealed a decreased intensive care unit stay in the RA versus RITA group (median 30.4 vs 36.2 hours, respectively, P = 0.005) but no significant difference in hospital length of stay. There was no significant difference in perioperative mortality or cardiac morbidity rates. RITA patients had a higher incidence of sternal wound infection (5.3% vs 0.6%, P = 0.01), however, and tended to have increased blood product transfusion rates (51% vs 40%, P = 0.06).
The use of 2 arterial grafts is safe, with a reduction in perioperative cardiac morbidity or mortality rates compared with 1 arterial graft after adjustment for other risk variables. When comparing RITA to RA as second arterial grafts, patients receiving an RA have a lower incidence of sternal wound infection and decreased transfusion requirements, with no difference in perioperative or intermediate-term cardiac morbidity or mortality rates.
在冠状动脉旁路移植术(CABG)期间,将左胸廓内动脉(LITA)移植至左前降支冠状动脉(LAD)的通畅率高于大隐静脉移植,且可降低长期心脏发病率和死亡率。多支动脉移植与单支动脉移植的益处以及不同动脉移植物在短期和中期结果方面的作用仍存在争议。本研究的目的是比较以下情况的围手术期和中期结果:(1)接受2支动脉移植的患者与接受1支动脉移植的患者;(2)接受右胸廓内动脉(RITA)作为第二支动脉移植的患者与接受桡动脉(RA)作为第二支动脉移植的患者。
对1989年至1996年在本机构连续接受单纯CABG的患者的前瞻性收集数据进行回顾性分析。研究的第一部分比较了1支动脉移植(LITA至LAD,n = 2333)与2支动脉移植(LITA + RA或LITA + RITA,n = 378)的结果。研究的第二部分比较了自1992年开始进行桡动脉系列研究以来,作为第二支动脉移植的RITA(n = 132)与RA(n = 171)的结果。第一部分:通过多变量逐步逻辑回归分析,根据我们目前的患者选择标准,使用1支动脉移植与围手术期心脏发病率和死亡率的增加相关(优势比2.2,95%置信区间1.4至3.3)。接受双动脉移植的患者在中期精算生存率(P = 0.12)和无心脏事件生存率(P = 0.09)方面有增加的趋势,但无统计学意义。第二部分:术前人口统计学比较显示,接受RA作为第二支动脉移植的患者与接受RITA的患者相比,糖尿病发病率更高(27%对11%,P < 0.001)、外周血管疾病发病率更高(16%对8%,P = 0.03)以及老年患者比例更高(13%对2%,P = 0.001)。围手术期结果分析显示,RA组与RITA组相比,重症监护病房停留时间缩短(中位数分别为30.4小时和36.2小时,P = 0.005),但住院时间无显著差异。围手术期死亡率或心脏发病率无显著差异。然而,RITA患者的胸骨伤口感染发生率更高(5.3%对0.6%,P = 0.01),且血液制品输注率有增加的趋势(51%对40%,P = 0.06)。
使用2支动脉移植是安全的,在对其他风险变量进行调整后,与1支动脉移植相比,围手术期心脏发病率或死亡率降低。当将RITA与RA作为第二支动脉移植进行比较时,接受RA的患者胸骨伤口感染发生率较低且输血需求减少,围手术期或中期心脏发病率或死亡率无差异。